deltatrials
Completed PHASE3 NCT00002727

Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord

A RANDOMIZED STUDY OF HYPERFRACTIONATION VERSUS CONVENTIONAL FRACTIONATION IN T2 SQUAMOUS CELL CARCINOMA OF THE VOCAL CORD

Sponsor: National Cancer Institute (NCI)

Conditions Head and Neck Cancer
Interventions radiation therapy
Updated 6 times since 2017 Last updated: Dec 30, 2016 Started: Apr 30, 1996 Primary completion: Oct 31, 2005 Completion: Dec 31, 2016

This PHASE3 trial investigates Head and Neck Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 6 recorded versions since 1996 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Apr 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • Radiation Therapy Oncology Group
Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States, Albany, United States, Albuquerque, United States, Allentown, United States, Amarillo, United States, Anderson, United States, Ann Arbor, United States, Annapolis, United States, Arlington Heights, United States, Atlanta, United States and 168 more location s